Total Funding
73
64
Total FundingVenture - Series Unknown raised
Growth Score 73 in past quarter
-7 pts
Heat Score 64 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
32561
ImmunoPhotonics develops immunotherapy-based treatments for cancer.
- David Anderson: Chief Scientific OfficerPast Role: University of Missouri, Entrepreneur in Residence-Technology Transfer
Tomas Hode: Co-Founder
About the Company
ImmunoPhotonics develops immunotherapy-based treatments for cancer. A minimally invasive therapeutic cancer vaccine for the treatment of metastatic solid tumors.
ImmunoPhotonics has a strategic partnership with Veterinary Cancer Therapeutics, LLC.
The company was founded in 2008 and is based in Columbia, Missouri.
